Sutimlimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sutimlimab, covering 2022-10-31 to 2023-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan [Phase 3]